Inside Labiotech 3 Jul 2024
2024 survey: What can Labiotech readers tell us about the biotech industry?
Explore key insights into the latest biotech industry trends based on our 2024 reader survey findings. Discover more now!
- Latest Posts
Best in Biotech 2 Jul 2024
Swiss biotech going strong in 2024: 18 companies to put on your radar
Switzerland is a booming biotech hotspot in Europe boasting many high-profile companies. Here are 18 promising Swiss biotech companies.
In Depth 1 Jul 2024
Special Olympics: How is biotechnology revolutionizing sports performance worldwide?
Find out about biotechnology’s impact on sports performance and recovery, from genetic profiling, stem cells, and wearable technologies.
In Depth 28 Jun 2024
Going nuclear: radiopharmaceuticals funding sees surge in 2024
Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research as biotechs nab major funding deals.
Podcast 28 Jun 2024
Priovant – finding treatments for autoimmune diseases
Listen to our conversation with Priovant Therapeutics, developing therapies for autoimmune diseases with high morbidity.
In Depth 27 Jun 2024
CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?
Discover more about CRISPR-Cas13, including how it differs from CRISPR-Cas9 and what the technology can be used for.
ADVERTISEMENT
ADVERTISEMENT
In Depth 27 Jun 2024
The 2024 drug approval list: Eight new treatments you should know about
In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year.
In Depth 26 Jun 2024
Biotech megadeals: Exploring the surge in $100M+ deals
Biotech and healtcare contributed to more than one out of three megadeals in 2024, find out the reasons behind it.
Best in Biotech 25 Jun 2024
Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024
Delve into the biotech landscape of the state of Georgia and discover seven companies leading the charge in the industry.
In Depth 24 Jun 2024
Troublesome acquisitions: when biotech M&A goes wrong
Dive deeper into the world of M&A, as we take a look at some of the most prominent failed acquisitions of the last decade.
Best in Biotech 21 Jun 2024
Five biotechnology colleges in India cultivating future leaders
Take a closer look at five biotechnology colleges in India offering courses that can lead to numerous opportunities for students.
Podcast 21 Jun 2024
How ADCs can deliver death cap mushroom toxins to treat cancer
Listen to our conversation with Heidelberg Pharma about its lead amanitin-based ADC product candidate, HDP-101.
ADVERTISEMENT
